March 2007

FDA Requests Withdrawal

Novartis Pulls Zelnorm From U.S. Market

(3/30/2007, 3:30 p.m.) -- Earlier today, FDA officials issued a public health advisory announcing that Novartis Pharmaceuticals Corp. has complied with an FDA request to immediately cease all U.S. sales and marketing of its prescription drug tegaserod maleate, sold as Zelnorm. More

AAFP to TRICARE: 'Address Our Concerns'

(3/30/2007, 3:10 p.m.)

AHRQ Offers You, Your Patients Tools to Promote Health

(3/30/2007, 2:55 p.m.)

Internists Weigh In on Pay-For-Performance, Public Reporting

(3/29/2007, 3:35 p.m.)